@FiercePharma: #ICYMI yesterday: U.S. judge orders Valeant, Ackman to face insider trading suit. Story | Follow @FiercePharma
@EricPFierce: ICYMI: #Novo makes sure Denmark gets some of the action as it starts massive build up. More | Follow @EricPFierce
@CarlyHFierce: U.S. judge orders Valeant, Ackman to face insider trading suit. Article | Follow @CarlyHFierce
> The Scottish Medicines Consortium gave its thumbs up to Merck & Co.'s ($MRK) cancer immunotherapy Keytruda in melanoma, Roche's ($RHHBY) Avastin for ovarian cancer, and Daiichi Sankyo's blood thinner Lixiana. Report
> The Trans-Pacific Partnership could limit the availability of affordable medicines, World Health Organization chief Margaret Chan said Thursday. Report
> Despite long-standing recommendations to screen patients using antipsychotics for diabetes annually, only 30% receive the tests, a study found. Report
> Some Affordable Care Act exchange plans have limited the number of HIV drugs covered or charge higher out-of-pocket costs for them, a new analysis found. Report
> Chinese regulators stiff-armed 11 new drug applications because of inadequate data in a quality-oriented crackdown. Report
Medical Device News
@FierceMedDev: AliveCor adds former Google exec as CEO to further consumer ECG push. Story | Follow @FierceMedDev
@VarunSaxena2: Boston Sci's Watchman hit by restrictive CMS coverage decision, recall over blood leakage. Article | Follow @VarunSaxena2
@EmilyWFierce: Women are suing Endo Health Solutions and Patheon for child support after contraceptive packaging mishap. More | Follow @EmilyWFierce
> Resurgent 23andMe CEO says the genetic testing company is not up for sale. Article
> Philips to launch pneumonia Dx wearable to prevent child deaths in poorer countries. News
Biotech News
@FierceBiotech: China's new pharma crackdown may help top companies. Story | Follow @FierceBiotech
@JohnCFierce: Gilead, Sanofi singled out as worst offenders in failing to disclose trial data. More | Follow @JohnCFierce
@DamianFierce: $HZNP "is threatening $ESRX's profiteering and exposing ... a lack of care for patients and respect for physicians." News | Follow @DamianFierce
> Biogen's risky Alzheimer's odyssey raises prospects for new biotech deals. Story
> Portola rolls toward approval for its 'breakthrough' anticoagulant antidote. More
CRO News
> Quintiles lends its data-crunching know-how to Apple's ResearchKit. More
> PPD deepens its Japanese focus with new joint venture leadership. Story
> WuXi and Lilly pair up to develop a cardio drug in China. Article
> CRO BioDuro merges with Formex after a private equity takeout. More
> Quintiles founder stepping down as chairman after 33 years. News
Pharma Manufacturing News
> Endo, Patheon sued over unplanned pregnancies tied to contraceptive mishap. Item
> CMO Formex and CRO BioDuro merge operations. More
> Cellular Biomedicine adds facility in China that will help with CAR-T processing. Story
> AmerisourceBergen says quality will be PharMEDium's distinguisher, but acknowledges 'quick diligence' ahead of deal. Report
> Pharma cargo thefts jump with $558,000 average losses reported. News
Pharma Asia News
> India's drug regulator handcuffed by low funding, lack of trained personnel. Story
> Japan's Astellas Pharma gets $727M for ailing dermatology unit as it swings to new areas. More
> WuXi and Eli Lilly in pact on cardio candidate development in China. Article
> Japanese ministry knocks Novartis unit, again, on side effects nondisclosure. News
> Daiichi loses Supreme Court decision on Apotex generic. More
And Finally... Pfizer's ($PFE) vitamin C supplement Emergen-C was among a list of supplement brands called out by CBC for failing to live up to their labels. Report